Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Travis Steed
BofA

Travis Steed

Bank of America Securities
Wall Street Analyst
★★★★☆
#429
on 13Foresight · ranked by our own returns
60%
Success Rate
+3.8%
Average Return
93 of 155 calls profitable · -143.2% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 60% of Travis Steed's ratings turned a profit when each position was held for 1 year — averaging +3.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

170 Buy 79 Hold 22 Sell
Travis's Stock Coverage 41 ratings · 2026-11-15
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
BSX
Boston Scientific
 Oct 30, 2026 BUY Strong Buy
+43.0% avg upside
38 analysts
$54.00
28.68% Upside
 +6.7% ·
SYK
Stryker
 Oct 30, 2026 BUY Strong Buy
+18.5% avg upside
38 analysts
 — +9.2% ·
MDT
Medtronic
 Oct 30, 2026 BUY Buy
+4.4% avg upside
38 analysts
$110.00
14.03% Upside
 +4.8% ·
ABT
Abbott Laboratories
 Oct 30, 2026 BUY Strong Buy
+8.5% avg upside
36 analysts
$115.00
8.24% Upside
 +2.2% ·
AXGN
AxoGen
 Oct 29, 2026 BUY Strong Buy
-17.4% avg upside
21 analysts
$62.00
25.67% Upside
 +11.8% ·
BLCO
Bausch + Lomb Corporation
 Oct 29, 2026 SELL Buy
+7.6% avg upside
20 analysts
 — -3.4% ·
GEHC
GE Healthcare Technologies Inc
 Oct 28, 2026 HOLD Strong Buy
+10.2% avg upside
23 analysts
$84.00
9.80% Upside
 +9.5% ·
SOLV
Solventum Corporation
 Oct 27, 2026 HOLD Buy
+12.8% avg upside
16 analysts
$100.00
22.88% Upside
 +7.3% ·
BBNX
Beta Bionics, Inc.
 Oct 27, 2026 HOLD Strong Buy
+45.7% avg upside
17 analysts
$22.00
31.39% Upside
 -23.2% ·
DXCM
Dexcom
 Oct 23, 2026 BUY Strong Buy
+31.4% avg upside
33 analysts
 — +6.9% ·
IART
Integra Lifesciences
 Oct 22, 2026 SELL Hold
+208.1% avg upside
22 analysts
$14.00
9.81% Upside
 -17.8% ·
ISRG
Intuitive Surgical
 Oct 21, 2026 BUY Strong Buy
+12.0% avg upside
37 analysts
$470.00
8.70% Upside
 +3.6% ·
TFX
Teleflex
 Oct 16, 2026 BUY Buy
+31.3% avg upside
20 analysts
$158.00
13.12% Upside
 +18.6% ·
HAE
Haemonetics
 Oct 08, 2026 BUY Buy
-20.9% avg upside
18 analysts
$140.00
17.06% Upside
 +2.7% ·
BDX
Becton Dickinson
 Oct 06, 2026 HOLD Buy
-0.4% avg upside
25 analysts
$200.00
1.15% Upside
 +19.6% ·
ZBH
Zimmer Biomet Holdings
 Sep 25, 2026 HOLD Buy
+20.5% avg upside
39 analysts
$110.00
16.29% Upside
 +13.6% ·
MOBI
Mobia Medical, Inc.
 Sep 17, 2026 BUY Strong Buy
+96.1% avg upside
4 analysts
$16.00
51.20% Upside
 +3.9% ·
KMTS
Kestra Medical Technologies Ltd.
 Sep 14, 2026 BUY Strong Buy
-4.8% avg upside
9 analysts
$30.00
1.14% Upside
 +18.9% ·
COO
Cooper Co
 Sep 10, 2026 HOLD Buy
+105.8% avg upside
21 analysts
$65.00
9.13% Upside
 +14.8% ·
MMED
MiniMed Group, Inc.
 Sep 01, 2026 BUY Strong Buy
+37.6% avg upside
17 analysts
$28.00
53.16% Upside
 -25.5% ·
GMED
Globus Medical
 Aug 19, 2026 BUY Strong Buy
+18.8% avg upside
24 analysts
$106.00
35.81% Upside
 -18.3% ·
CARL
Carlsmed, Inc.
 Aug 13, 2026 BUY Strong Buy
+25.4% avg upside
6 analysts
 — +23.3% ·
CBLL
Ceribell, Inc.
 Aug 11, 2026 BUY Strong Buy
-1.6% avg upside
8 analysts
 — +23.6% ·
BAX
Baxter International
 Aug 11, 2026 HOLD Buy
+45.2% avg upside
23 analysts
$28.00
21.71% Upside
 -6.7% ·
EMBC
Embecta Corporation
 Aug 10, 2026 SELL Sell
+60.0% avg upside
5 analysts
 — -28.5% ·
TNDM
Tandem Diabetes Care
 Aug 07, 2026 HOLD Buy
+64.3% avg upside
29 analysts
$25.00
30.92% Upside
 -10.3% ·
RXST
RxSight
 Aug 05, 2026 SELL Hold
+85.9% avg upside
13 analysts
$6.50
33.41% Upside
 +13.5% ·
SIBN
SI-Bone
 Aug 04, 2026 BUY Strong Buy
+22.7% avg upside
18 analysts
 — +27.1% ·
INSP
Inspire Medical Systems
 Aug 04, 2026 SELL Buy
+30.4% avg upside
21 analysts
$45.00
33.92% Downside
 +4.7% ·
MMSI
Merit Medical Systems
 Jul 31, 2026 HOLD Strong Buy
+15.6% avg upside
16 analysts
 — +4.0% ·
CNMD
Conmed
 Jul 30, 2026 SELL Hold
+48.7% avg upside
12 analysts
 — -7.9% ·
EW
Edwards Lifesciences
 Jul 21, 2026 BUY Strong Buy
+10.0% avg upside
35 analysts
$100.00
8.65% Upside
 +26.7% ·
PODD
Insulet
 Jun 23, 2026 BUY Strong Buy
+40.0% avg upside
32 analysts
$208.00
38.97% Upside
 +6.0% ·
PEN
Penumbra
 Jan 15, 2026 BUY Buy
+3.6% avg upside
23 analysts
 — -8.4% ·
PRCT
PROCEPT BioRobotics
 Nov 05, 2025 BUY Buy
+59.9% avg upside
18 analysts
 — -35.9% ·
ITGR
Integer Holdings
 Oct 24, 2025 HOLD Buy
-18.9% avg upside
16 analysts
$87.00
31.20% Downside
 +73.6% ·
OM
Outset Medical
 May 13, 2024 SELL Buy
+314.7% avg upside
8 analysts
$3.00
25.57% Downside
 +62.9% ·
LUNG
Pulmonx
 Sep 29, 2023 HOLD Buy
+152.1% avg upside
9 analysts
 — -19.8% ·
DXC
DXC Technology
 Jan 06, 2021 SELL Hold
+82.5% avg upside
22 analysts
$24.00
60.31% Upside
 -27.5% ·
LNTH
Lantheus
 Sep 27, 2017 BUY Buy
-19.7% avg upside
21 analysts
$22.00
78.02% Downside
 -17.1% ·
VRAYQ
Viewray
 Aug 07, 2017 BUY Strong Buy
+558333233.3% avg upside
12 analysts
 — · ·
🔒 36 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Travis Steed — Frequently Asked Questions
How accurate are Travis Steed's stock ratings?
Based on the calls 13Foresight could measure, about 60% of Travis's ratings were profitable over a one-year hold, with an average return of +3.8% per rating, or -143.2% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Travis ranked on 13Foresight?
Travis Steed is currently ranked #429 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Travis cover?
Travis most recently has ratings on BSX, SYK, MDT, ABT, AXGN, BLCO, GEHC, SOLV, BBNX, DXCM, IART, ISRG and 29 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.